Epigenetics: A Promising Paradigm for Better Understanding and Managing Pain

Beyer, 2004, Effect of the a118g polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor, J Neurochem, 89, 553, 10.1111/j.1471-4159.2004.02340.x

Bond, 1998, Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction, Proc Natl Acad Sci U S A, 95, 9608, 10.1073/pnas.95.16.9608

Borner, 2002, Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene, Mol Pharmacol, 61, 800, 10.1124/mol.61.4.800

Caspary, 1998, Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster, Mol Cell Biol, 18, 3466, 10.1128/MCB.18.6.3466

Chiechio, 2009, Epigenetic modulation of mglu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain, Mol Pharmacol, 75, 1014, 10.1124/mol.108.054346

Doehring, 2011, Epigenetics in pain and analgesia: An imminent research field, Eur J Pain, 15, 11, 10.1016/j.ejpain.2010.06.004

Dostie, 2003, Numerous micrornps in neuronal cells containing novel micrornas, RNA, 9, 180, 10.1261/rna.2141503

Elmer, 1998, Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests, Pain, 75, 129, 10.1016/S0304-3959(97)00215-7

Esteller, 2008, Epigenetics in cancer, N Engl J Med, 358, 1148, 10.1056/NEJMra072067

Fire, 1998, Potent and specific genetic interference by double-stranded rna in caenorhabditis elegans, Nature, 391, 806, 10.1038/35888

Flores, 2001, The pharmacogenetics of analgesia: Toward a genetically-based approach to pain management, Pharmacogenomics, 2, 177, 10.1517/14622416.2.3.177

Fukagawa, 2004, Dicer is essential for formation of the heterochromatin structure in vertebrate cells, Nat Cell Biol, 6, 784, 10.1038/ncb1155

Fuks, 2003, The DNA methyltransferases associate with hp1 and the suv39h1 histone methyltransferase, Nucleic Acids Res, 31, 2305, 10.1093/nar/gkg332

Garraway, 2007, Design and evaluation of small interfering rnas that target expression of the n-methyl-d-aspartate receptor nr1 subunit gene in the spinal cord dorsal horn, J Pharmacol Exp Ther, 322, 982, 10.1124/jpet.107.123125

Geranton, 2012, Targeting epigenetic mechanisms for pain relief, Curr Opin Pharmacol, 12, 35, 10.1016/j.coph.2011.10.012

Grant, 1998, A subset of taf(ii)s are integral components of the saga complex required for nucleosome acetylation and transcriptional stimulation, Cell, 94, 45, 10.1016/S0092-8674(00)81220-9

Grzenda, 2009, Sin3: Master scaffold and transcriptional corepressor, Biochim Biophys Acta, 1789, 443, 10.1016/j.bbagrm.2009.05.007

Guo, 2006, Supraspinal brain-derived neurotrophic factor signaling: A novel mechanism for descending pain facilitation, J Neurosci, 26, 126, 10.1523/JNEUROSCI.3686-05.2006

Hake, 2006, Histone h3 variants and their potential role in indexing mammalian genomes: The “H3 barcode hypothesis”, Proc Natl Acad Sci U S A, 103, 6428, 10.1073/pnas.0600803103

Hall, 2002, Establishment and maintenance of a heterochromatin domain, Science, 297, 2232, 10.1126/science.1076466

He, 2010, Regulation of opioid tolerance by let-7 family microrna targeting the mu opioid receptor, J Neurosci, 30, 10251, 10.1523/JNEUROSCI.2419-10.2010

Hwang, 2003, Mouse mu opioid receptor distal promoter transcriptional regulation by sox proteins, J Biol Chem, 278, 3742, 10.1074/jbc.M208780200

Hwang, 2004, Transcriptional regulation of mouse mu opioid receptor gene by pu.1, J Biol Chem, 279, 19764, 10.1074/jbc.M400755200

Hwang, 2010, Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells, Mol Pharmacol, 78, 58, 10.1124/mol.110.064311

Hwang, 2009, Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by mecp2 and brg1 chromatin remodelling factor, J Cell Mol Med, 13, 3591, 10.1111/j.1582-4934.2008.00535.x

Im, 2001, Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by sox18, Mol Pharmacol, 59, 1486, 10.1124/mol.59.6.1486

Istrail, 2005, Logic functions of the genomic cis-regulatory code, Proc Natl Acad Sci U S A, 102, 4954, 10.1073/pnas.0409624102

Jenuwein, 2001, Translating the histone code, Science, 293, 1074, 10.1126/science.1063127

Kanellopoulou, 2005, Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing, Genes Dev, 19, 489, 10.1101/gad.1248505

Kanno, 2004, Selective recognition of acetylated histones by bromodomain proteins visualized in living cells, Mol Cell, 13, 33, 10.1016/S1097-2765(03)00482-9

Karpf, 2005, Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells, Cancer Res, 65, 8635, 10.1158/0008-5472.CAN-05-1961

Kasama, 2007, Rna interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat, Eur J Neurosci, 25, 2956, 10.1111/j.1460-9568.2007.05584.x

Kieffer, 2002, Opioid tolerance-in search of the holy grail, Cell, 108, 587, 10.1016/S0092-8674(02)00666-9

Kim, 2005, Poly(c) binding protein family is a transcription factor in mu-opioid receptor gene expression, Mol Pharmacol, 68, 729, 10.1124/mol.105.012245

Kraus, 2003, The role of nuclear factor kappab in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene, Mol Pharmacol, 64, 876, 10.1124/mol.64.4.876

Lachner, 2001, Methylation of histone h3 lysine 9 creates a binding site for hp1 proteins, Nature, 410, 116, 10.1038/35065132

Lacroix-Fralish, 2009, Progress in genetic studies of pain and analgesia, Annu Rev Pharmacol Toxicol, 49, 97, 10.1146/annurev-pharmtox-061008-103222

Langst, 1999, Nucleosome movement by chrac and iswi without disruption or trans-displacement of the histone octamer, Cell, 97, 843, 10.1016/S0092-8674(00)80797-7

Lee, 2003, Transcriptional regulation of mu opioid receptor gene by cAMP pathway, Mol Pharmacol, 64, 1410, 10.1124/mol.64.6.1410

LeRoy, 1998, Requirement of rsf and fact for transcription of chromatin templates in vitro, Science, 282, 1900, 10.1126/science.282.5395.1900

Lomberk, 2005, The family feud: Turning off sp1 by sp1-like klf proteins, Biochem J, 392, 1, 10.1042/BJ20051234

Lomberk, 2006, Evidence for the existence of an hp1-mediated subcode within the histone code, Nat Cell Biol, 8, 407, 10.1038/ncb1383

Lu, 2010, Trichostatin a, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice, Hum Reprod, 25, 1014, 10.1093/humrep/dep472

Ma, 2004, Brg-1 is required for maximal transcription of the human matrix metalloproteinase-2 gene, J Biol Chem, 279, 46326, 10.1074/jbc.M405438200

Marmorstein, 2009, Histone modifying enzymes: Structures, mechanisms, and specificities, Biochim Biophys Acta, 1789, 58, 10.1016/j.bbagrm.2008.07.009

Mizuguchi, 2004, Atp-driven exchange of histone h2az variant catalyzed by swr1 chromatin remodeling complex, Science, 303, 343, 10.1126/science.1090701

Mogil, 2012, Pain genetics: Past, present and future, Trends Genet, 28, 258, 10.1016/j.tig.2012.02.004

Muralidharan, 2011, Pain, analgesia and genetics, J Pharm Pharmacol, 63, 1387, 10.1111/j.2042-7158.2011.01340.x

Nakayama, 2001, Role of histone h3 lysine 9 methylation in epigenetic control of heterochromatin assembly, Science, 292, 110, 10.1126/science.1060118

Oertel, 2012, Genetic-epigenetic interaction modulates mu-opioid receptor regulation, Hum Mol Genet, 21, 4751, 10.1093/hmg/dds314

Orphanides, 1998, Fact, a factor that facilitates transcript elongation through nucleosomes, Cell, 92, 105, 10.1016/S0092-8674(00)80903-4

Owen, 1998, Progesterone regulates transcription of the p21(waf1) cyclin- dependent kinase inhibitor gene through sp1 and cbp/p300, J Biol Chem, 273, 10696, 10.1074/jbc.273.17.10696

Peters, 2002, Histone h3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin, Nat Genet, 30, 77, 10.1038/ng789

Peterson, 2000, Promoter targeting and chromatin remodeling by the swi/snf complex, Curr Opin Genet Dev, 10, 187, 10.1016/S0959-437X(00)00068-X

Rodriguez-Menendez, 2008, Targeting cancer and neuropathy with histone deacetylase inhibitors: Two birds with one stone?, Curr Cancer Drug Targets, 8, 266, 10.2174/156800908784533508

Sharma, 2010, Epigenetics in cancer, Carcinogenesis, 31, 27, 10.1093/carcin/bgp220

Sibille, 2012, Telomeres and epigenetics: Potential relevance to chronic pain, Pain, 153, 1789, 10.1016/j.pain.2012.06.003

Smallwood, 2007, Functional cooperation between hp1 and dnmt1 mediates gene silencing, Genes Dev, 21, 1169, 10.1101/gad.1536807

Smith, 2009, Chemical mechanisms of histone lysine and arginine modifications, Biochim Biophys Acta, 1789, 45, 10.1016/j.bbagrm.2008.06.005

Smith, 2012, Pharmacogenetics of pain and analgesia, Clin Genet, 82, 321, 10.1111/j.1399-0004.2012.01936.x

Somogyi, 2007, Pharmacogenetics of opioids, Clin Pharmacol Ther, 81, 429, 10.1038/sj.clpt.6100095

Strahl, 2000, The language of covalent histone modifications, Nature, 403, 41, 10.1038/47412

Sudarsanam, 2000, The swi/snf family nucleosome-remodeling complexes and transcriptional control, Trends Genet, 16, 345, 10.1016/S0168-9525(00)02060-6

Szyf, 2009, Epigenetics, DNA methylation, and chromatin modifying drugs, Annu Rev Pharmacol Toxicol, 49, 243, 10.1146/annurev-pharmtox-061008-103102

Tan, 2005, Gene knockdown with intrathecal sirna of nmda receptor nr2b subunit reduces formalin-induced nociception in the rat, Gene Ther, 12, 59, 10.1038/sj.gt.3302376

Thompson, 2001, Transcriptional coactivator protein p300. Kinetic characterization of its histone acetyltransferase activity, J Biol Chem, 276, 33721, 10.1074/jbc.M104736200

Tremblay, 2010, Genetics of pain, opioids, and opioid responsiveness, Metabolism, 59, S5, 10.1016/j.metabol.2010.07.015

Tsukiyama, 1999, Characterization of the imitation switch subfamily of atp-dependent chromatin-remodeling factors in saccharomyces cerevisiae, Genes Dev, 13, 686, 10.1101/gad.13.6.686

Volpe, 2002, Regulation of heterochromatic silencing and histone h3 lysine-9 methylation by rnai, Science, 297, 1833, 10.1126/science.1074973

Wang, 2004, Beyond the double helix: Writing and reading the histone code, Novartis Found Symp, 259, 3, 10.1002/0470862637.ch2

Wei, 2011, Transcriptional, epigenetic regulation of opioid receptor genes: Present and future, Annu Rev Pharmacol Toxicol, 51, 75, 10.1146/annurev-pharmtox-010510-100605

Woolf, 1994, Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity, Neuroscience, 62, 327, 10.1016/0306-4522(94)90366-2

Wu, 2008, Post-transcriptional regulation of mouse mu opioid receptor (mor1) via its 3' untranslated region: A role for microrna23b, FASEB J, 22, 4085, 10.1096/fj.08-108175

Xue, 1998, Nurd, a novel complex with both atp-dependent chromatin-remodeling and histone deacetylase activities, Mol Cell, 2, 851, 10.1016/S1097-2765(00)80299-3

Zubieta, 2003, Comt val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor, Science, 299, 1240, 10.1126/science.1078546